Retrospective Review of Combined Sirolimus and Simvastatin Therapy in Lymphangioleiomyomatosis

BACKGROUND: Combined simvastatin and sirolimus therapy reduces tuberous sclerosis complex 2-null lesions and alveolar destruction in a mouse model of lymphangioleiomyomatosis (LAM), suggesting that therapy with both drugs may benefit patients with LAM. METHODS: To determine whether simvastatin chang...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Chest
Autors principals: Taveira-DaSilva, Angelo M., Jones, Amanda M., Julien-Williams, Patricia A., Stylianou, Mario, Moss, Joel
Format: Artigo
Idioma:Inglês
Publicat: American College of Chest Physicians 2015
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4285076/
https://ncbi.nlm.nih.gov/pubmed/25167325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.14-0758
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars